BeyondSpring (BYSI) Competitors $1.78 +0.03 (+1.71%) Closing price 03:53 PM EasternExtended Trading$1.77 -0.01 (-0.56%) As of 05:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BYSI vs. SOPH, ALLO, DBVT, RNAC, LYEL, ACIU, JBIO, AARD, JMAC, and IMMPShould you be buying BeyondSpring stock or one of its competitors? The main competitors of BeyondSpring include SOPHiA GENETICS (SOPH), Allogene Therapeutics (ALLO), DBV Technologies (DBVT), Cartesian Therapeutics (RNAC), Lyell Immunopharma (LYEL), AC Immune (ACIU), Jade Biosciences (JBIO), Aardvark Therapeutics (AARD), Maxpro Capital Acquisition (JMAC), and Prima BioMed (IMMP). These companies are all part of the "pharmaceutical products" industry. BeyondSpring vs. Its Competitors SOPHiA GENETICS Allogene Therapeutics DBV Technologies Cartesian Therapeutics Lyell Immunopharma AC Immune Jade Biosciences Aardvark Therapeutics Maxpro Capital Acquisition Prima BioMed BeyondSpring (NASDAQ:BYSI) and SOPHiA GENETICS (NASDAQ:SOPH) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, media sentiment, earnings, dividends, analyst recommendations, risk, valuation and institutional ownership. Do insiders & institutionals hold more shares of BYSI or SOPH? 40.3% of BeyondSpring shares are held by institutional investors. Comparatively, 31.6% of SOPHiA GENETICS shares are held by institutional investors. 29.3% of BeyondSpring shares are held by company insiders. Comparatively, 4.9% of SOPHiA GENETICS shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Is BYSI or SOPH more profitable? BeyondSpring has a net margin of 0.00% compared to SOPHiA GENETICS's net margin of -40.99%. BeyondSpring's return on equity of 0.00% beat SOPHiA GENETICS's return on equity.Company Net Margins Return on Equity Return on Assets BeyondSpringN/A N/A N/A SOPHiA GENETICS -40.99%-30.69%-17.39% Which has more risk & volatility, BYSI or SOPH? BeyondSpring has a beta of 0.24, meaning that its share price is 76% less volatile than the S&P 500. Comparatively, SOPHiA GENETICS has a beta of 1.1, meaning that its share price is 10% more volatile than the S&P 500. Do analysts recommend BYSI or SOPH? SOPHiA GENETICS has a consensus price target of $8.00, suggesting a potential upside of 97.53%. Given SOPHiA GENETICS's stronger consensus rating and higher possible upside, analysts plainly believe SOPHiA GENETICS is more favorable than BeyondSpring.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BeyondSpring 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00SOPHiA GENETICS 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the media refer more to BYSI or SOPH? In the previous week, SOPHiA GENETICS had 3 more articles in the media than BeyondSpring. MarketBeat recorded 3 mentions for SOPHiA GENETICS and 0 mentions for BeyondSpring. SOPHiA GENETICS's average media sentiment score of 0.74 beat BeyondSpring's score of 0.00 indicating that SOPHiA GENETICS is being referred to more favorably in the news media. Company Overall Sentiment BeyondSpring Neutral SOPHiA GENETICS Positive Which has higher valuation & earnings, BYSI or SOPH? BeyondSpring has higher earnings, but lower revenue than SOPHiA GENETICS. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBeyondSpring$1.75M41.02-$11.12MN/AN/ASOPHiA GENETICS$69.69M3.93-$62.49M-$0.44-9.20 SummaryBeyondSpring and SOPHiA GENETICS tied by winning 7 of the 14 factors compared between the two stocks. Get BeyondSpring News Delivered to You Automatically Sign up to receive the latest news and ratings for BYSI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BYSI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BYSI vs. The Competition Export to ExcelMetricBeyondSpringMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$71.79M$3.35B$6.10B$10.62BDividend YieldN/A2.28%5.64%4.69%P/E RatioN/A22.1685.6627.13Price / Sales41.02265.75527.82206.05Price / CashN/A46.3226.3031.10Price / Book-4.819.9612.926.67Net Income-$11.12M-$52.42M$3.30B$276.23M7 Day Performance2.30%5.95%4.80%3.31%1 Month Performance-4.30%11.59%8.11%10.76%1 Year Performance-24.89%25.01%75.85%33.58% BeyondSpring Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BYSIBeyondSpringN/A$1.78+1.7%N/A-26.2%$71.79M$1.75M0.0080Positive NewsGap UpSOPHSOPHiA GENETICS2.6535 of 5 stars$3.96+0.8%$8.00+102.0%+33.7%$267.62M$65.17M-9.00520Short Interest ↓ALLOAllogene Therapeutics2.8422 of 5 stars$1.17flat$8.44+621.7%-50.7%$259.60M$20K-1.05310Positive NewsAnalyst UpgradeDBVTDBV Technologies2.4322 of 5 stars$9.35-1.6%$14.75+57.8%+268.6%$256.19M$4.15M-1.9680News CoveragePositive NewsGap UpRNACCartesian Therapeutics2.1858 of 5 stars$9.81-2.3%$40.00+307.7%-58.4%$255.06M$38.91M-0.1964LYELLyell Immunopharma1.4044 of 5 stars$13.18+0.1%$15.00+13.8%-27.3%$253.19M$60K-0.54270Positive NewsACIUAC Immune2.2834 of 5 stars$2.52-0.4%$10.00+296.8%+18.0%$253.03M$31.02M-4.34140Positive NewsJBIOJade Biosciences2.0812 of 5 stars$7.61-3.9%$16.00+110.2%N/A$248.31MN/A-0.2520AARDAardvark Therapeutics4.5137 of 5 stars$11.44+1.9%$32.60+185.0%N/A$248.25MN/A0.0018Short Interest ↓Gap UpJMACMaxpro Capital AcquisitionN/A$18.43flatN/AN/A$247.52MN/A0.002,021IMMPPrima BioMed1.0463 of 5 stars$1.65-3.5%$7.00+324.2%-9.3%$242.20M$6.69M0.002,021 Related Companies and Tools Related Companies SOPH Competitors ALLO Competitors DBVT Competitors RNAC Competitors LYEL Competitors ACIU Competitors JBIO Competitors AARD Competitors JMAC Competitors IMMP Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BYSI) was last updated on 10/6/2025 by MarketBeat.com Staff From Our Partners$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredGet my No. 1 gold stock nowGold recently broke past $3,800 per ounce – setting yet another new all-time high. And Wall Street banks sa...Stansberry Research | SponsoredThe $20 stock that could make silicon chips obsolete$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BeyondSpring Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BeyondSpring With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
